首页 >
法规速递
-
Document: Paediatric addendum to CHMP guideline on the clinical investigations of medicinal products for the treatment of pulmonary arterial hypertension-2026/3/31
2026-04-01查看详情 > -
Document: Concept paper on the need for revision of the guideline on clinical investigation of medicinal products for the treatment of amyotrophic lateral sclerosis-2026/3/31
2026-04-01查看详情 > -
Page: Clinical investigation of medicinal products for the treatment of amyotrophic lateral sclerosis - Scientific guideline-2026/3/31
2026-04-01查看详情 > -
Page: Opinions and letters of support on the qualification of novel methodologies for medicine development-2026/3/3/1
2026-04-01查看详情 > -
Document: Draft Qualification opinion for Virtual Control Groups (VCG) to replace Concurrent Control Groups (CCG) in rat non-GLP Dose-Range Finding (DRF) studies-2026/3/31
2026-04-01查看详情 > -
Document: Annex 4 - Initial Qualification Procedure List of Issues and Replies - Virtual Control Groups-2026/3/31
2026-04-01查看详情 > -
Document: Annex 3 - CHMP Scientific Advice - Summary Qualification Document-2026/3/31
2026-04-01查看详情 > -
Page: Scientific publications-2026/3/31
2026-04-01查看详情 > -
Document: Annex 1 - Standard Operating Procedure for the Implementation of Virtual Control Groups in Preclinical Studies-2026/3/31
2026-04-01查看详情 > -
Page: European medicines agencies network strategy (EMANS)-2026/3/31
2026-04-01查看详情 >
